Acute Kidney Injury in Intensive Care Patients
AKI-ICU
Incidence, Risk Factors, and Outcomes for Acute Kidney Injury in Intensive Care Patients: a Prospective Observational Study
1 other identifier
observational
174
1 country
1
Brief Summary
The goal of this prospective observational study is to evaluate the incidence, risk factors, and outcomes for development of acute kidney injury (AKI) in intensive care pateints. The main questions it aims to answer are:
- What is the incidence of acute kidney injury in intensive care patients?
- What are risk factors for development of acute kidney injury? All adult patients admitted to the ICU with a stay of 48 h or more will be included in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2023
CompletedFirst Submitted
Initial submission to the registry
July 24, 2023
CompletedFirst Posted
Study publicly available on registry
August 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedJune 10, 2026
November 1, 2025
4 months
July 24, 2023
June 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess the incidence of acute kidney injury in ICU patients
During their management lasting more than 48 hours in the ICU, some patients develop acute kidney injury.
Up to 28 day
Eligibility Criteria
The patients who developed acute kidney inhury during intensive care unit stay.
You may qualify if:
- All adult patients admitted to the ICU with a stay of 48 h or more
You may not qualify if:
- Patients with missing data, end-stage renal disease, existence of AKI at the time of ICU admission or history of renal transplantation will be excluded from the study. Patients that were readmitted to the ICU within 48 h will reunited with the first admission and be considered as one admission for the analysis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Science University, Haseki Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sinan Uzman, Assoc. prof.
Health Science Unibersity, Haseki Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ICU consultant, Associate professor
Study Record Dates
First Submitted
July 24, 2023
First Posted
August 2, 2023
Study Start
May 28, 2023
Primary Completion
September 30, 2023
Study Completion
November 1, 2025
Last Updated
June 10, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share